期刊文献+

17例淋巴瘤相关噬血细胞综合征的临床特点及疗效分析

Clinical characteristics and therapeutic effect of 17 cases of lymphoma-associated hemophagocytic syndrome
下载PDF
导出
摘要 目的:总结淋巴瘤相关噬血细胞综合征(LAHS)的临床特点及疗效。方法分析17例 LAHS 患者的临床资料,总结其临床特点及疗效。结果17例患者均持续高热1周以上,15例出现脾大;17例血清铁蛋白均明显升高;16例出现全血细胞减少及高甘油三酯血症;14例有低纤维蛋白原血症;17例骨髓中均有噬血现象。17例中2例于化学治疗后接受异基因外周血造血干细胞移植术,已分别存活45个月及37个月;1例于化学治疗后接受自体外周血造血干细胞移植术,术后11个月死于感染;13例仅接受化学治疗者中1例存活15个月,其余12例均死亡,生存期为3~13个月。1例入院1周后即死亡者未接受治疗。结论LAHS 起病急、病情重,患者常有高热、脾大、血细胞减少、高血清铁蛋白及高甘油三酯血症,骨髓可见噬血现象。该类患者化学治疗疗效差,外周血造血干细胞移植术可能是较有效的治疗方法。 Objective To summarize the clinical characteristics and therapeutic effect of 1 7 cases of lymphoma-associated hemophagocytic syndrome (LAHS).Methods The clinical data were analyzed to sum-marize the clinical features and therapeutic effect of 1 7 patients with LAHS.Results High-grade fever,high serum level of ferritin and hemophagocytosis were observed in 1 7 cases,cytopenia and hypertriglyceridemia in 1 6,splenomegaly in 1 5 and hypofibrinogenemia in 1 4.Two patients who received chemotherapy and then allo-geneic peripheral blood stem cell transplantation (allo-PBSCT)survived for 45 and 37 months.One case un-dergoing chemotherapy and then autologous peripheral blood stem cell transplantation (auto-PBSCT)died of in-fection at postoperative 1 5 months.Among 1 3 patients who received chemotherapy alone,only 1 case survived for 1 5 months after 8 cycles of chemotherapy and the other 1 2 died with a survival time ranging from 3 to 1 3 months.One case died one week after admission without any treatment.Conclusions LAHS is characterized as acute onset,severe condition,high-grade fever,hypertriglyceridemia,cytopenia,hemophagocytosis,high serum level of ferritin and hypertriglyceridemia.Chemotherapy yields relatively poor therapeutic effect,whereas allo-PBSCT may serve as an efficacious treatment of LAHS.
出处 《新医学》 2014年第10期659-662,共4页 Journal of New Medicine
关键词 噬血细胞综合征 淋巴瘤 临床特点 疗效 Hemophagocytic syndrome Lymphoma Clinical characteristics Therapeutic effect
  • 相关文献

参考文献9

二级参考文献36

  • 1沈丰一,潘祖玉.噬血细胞综合征[J].上海医学,2005,28(2):168-171. 被引量:15
  • 2Henter J I,Horne A,Aricò M,et al.HLH 2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48 (2):124.
  • 3Imashuku S.Advances in the management of hemophagocytic lymphohistiocytosis[J].Int J Hematol,2000,72 (1):1.
  • 4Takahashi N.Lymphoma-associated hemophagocytic syndrome(LAH-S)[J].Nippon Rinsho,2000,58(3):665.
  • 5Ohno T,UedaY,Nagai K.Theserumcytokine profiles of lymphoma-associated hemophagocytic syndrome:a comparative analysis of B-cell and T-cell/naturalkiller cell lymphomas[J].Int J Hematol,2003,77(3):286.
  • 6Takahashi N,Miura I,Chubachi A.A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-celllymphoma[J].Int J Hematol,2001,74(3):303.
  • 7Chen RL, Su IJ,Lin KH, et al.Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullaryreticulosis :an atypical form of EBV infection [J]. Am J Clin Pathol, 1991,96(2): 171-176.
  • 8HenterJ, Samuetsson A, Ericson K, et al. Familial hemophago- cytic lymphohistiocytosis:diagnosis,treatment and pathophy- siological mechanisms [J]. Laartidningen, 2000,97 (12) : 1405-1408.
  • 9Wilson MS,Welss LM , Gatter KC, et al.Malignant histio- cytosis:a reassesment of cases previously in 1975 based on paraffin section im munophenotyping studies[J].Cancer, 1990,66(3) : 530-536.
  • 10Kurzrock R. Therapy of T cell lymphomas with pentostatin [J]. Ann N Y Acad Sci,2001,941:200-205.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部